RECURRENT
Clinical trials for RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECURRENT trials appear
Sign up with your email to follow new studies for RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune combo shows promise against stubborn lymphoma
Disease control CompletedThis study tested a combination of three drugs (DPX-Survivac, low-dose cyclophosphamide, and pembrolizumab) in 25 adults with diffuse large B-cell lymphoma that had come back or not responded to prior treatments. The goal was to see if the immune system could be boosted to shrink…
Matched conditions: RECURRENT
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
Gene-Tailored drugs show promise for rare salivary gland cancer
Disease control CompletedThis study looked at whether giving people with advanced salivary gland cancer a drug that matches their tumor's genetic makeup can help control the disease. 114 participants first had their tumor genes analyzed. If a targetable change was found, they got a matched drug; if not, …
Matched conditions: RECURRENT
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Cow colostrum shows promise in stopping Kids' UTIs
Prevention CompletedThis study tested whether a supplement from cow's first milk (bovine colostrum) could prevent repeat urinary tract infections (UTIs) in 60 children. The goal was to see if this natural product, which contains immune-boosting substances, could be a safe alternative to antibiotics.…
Matched conditions: RECURRENT
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Prevention
Last updated May 17, 2026 04:14 UTC
-
Hernia surgery showdown: fewer fixation points may mean less pain
Symptom relief CompletedThis study looked at 351 adults with inguinal hernia who had keyhole surgery (TAPP). Doctors compared using 3 points versus 1 point to fix the mesh inside. The goal was to see which method caused less pain, fewer complications like fluid buildup or infection, and lower chance of …
Matched conditions: RECURRENT
Phase: NA • Sponsor: Nanchong Central Hospital • Aim: Symptom relief
Last updated May 17, 2026 04:15 UTC